Tagworks Pharmaceuticals
Nijmegen, Gelderland, Netherlands · Biotechnology, Health Care, Pharmaceutical
Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing pr
Key facts
- Headquarters
- Nijmegen, Gelderland, Netherlands
- Employees
- 37
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Status
- Private
- Website
- www.tagworkspharma.com
- Company page
Recent activity at Tagworks Pharmaceuticals
- : Tagworks Pharmaceuticals Appoints Keith Orford as Chief Medical Officer
- : Tagworks Pharmaceuticals BV Appoints Ken Mills as Chief Executive Officer
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Keith Orford, Chief Medical Officer
- Marc Robillard, Chief Scientific Officer
- Ken Mills, Chief Executive Officer
- Raffaella Rossin, Vice President
Verified email and direct lines for Tagworks Pharmaceuticals’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Companies similar to Tagworks Pharmaceuticals
- Arecor Therapeutics PLC · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Windward Bio · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Specialised Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Anavex Life Sciences · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- AIM ImmunoTech · Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Tagworks Pharmaceuticals: questions and answers
What does Tagworks Pharmaceuticals do?
Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing pr
Where is Tagworks Pharmaceuticals headquartered?
Tagworks Pharmaceuticals is headquartered in Nijmegen, Gelderland, Netherlands.
How many employees does Tagworks Pharmaceuticals have?
Tagworks Pharmaceuticals has about 37 employees.
Who leads Tagworks Pharmaceuticals?
Ken Mills is a Chief Executive Officer at Tagworks Pharmaceuticals.
What is the latest news on Tagworks Pharmaceuticals?
On Apr 22, 2025, Tagworks Pharmaceuticals Appoints Keith Orford as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy